Search Prime Contracts

75A50124C00062

Definitive Contract

Overview

Government Description
DEVELOPMENT OF HOPO-101 AS AN MCM (MEDICAL COUNTERMEASURE) DECORPORATION AGENT FOR THE TREATMENT OF INDIVIDUALS WITH KNOWN OR SUSPECTED INTERNAL CONTAMINATION WITH RADIONUCLIDES (THE ?MCM INDICATION?) AND/OR TOXIC HEAVY METALS OF INTEREST FOR COMMERC
Place of Performance
Berkeley, CA 94704 United States
Pricing
Cost Plus Fixed Fee
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
252
Hopo Therapeutics was awarded Definitive Contract 75A50124C00062 (75A501-24-C-00062) worth up to $226,309,811 by the HHS Office of the Assistant Secretary for Preparedness and Response in September 2024. The contract has a duration of 5 years and was awarded through solicitation Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) full & open with NAICS 541715 and PSC Q701 via direct negotiation acquisition procedures with 1 bid received. As of today, the Definitive Contract has a total reported backlog of $216,940,287.

Status
(Open)

Last Modified 9/27/24
Period of Performance
9/30/24
Start Date
12/31/25
Current End Date
9/30/29
Potential End Date
9.0% Complete

Obligations and Backlog
$9.4M
Total Obligated
$9.4M
Current Award
$226.3M
Potential Award
4% Funded
$0.0
Funded Backlog
$216.9M
Total Backlog

Award Hierarchy

Definitive Contract

75A50124C00062

Subcontracts

0

Activity Timeline

Interactive chart of timeline of amendments to 75A50124C00062

Opportunity Lifecycle

Procurement history for 75A50124C00062

People

Suggested agency contacts for 75A50124C00062

Competition

Number of Bidders
1
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Performance Based Acquisition
Yes
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
H5MWN5ZBXQ98
Awardee CAGE
8L3L6
Agency Detail
Awarding Office
75A501 BARDA - ASPR / DAAPPO / BARDA DCMA
Funding Office
75A501
Created By
hhseringreninger1
Last Modified By
hhseringreninger1
Approved By
hhseringreninger1

Legislative

Legislative Mandates
None Applicable
Performance District
CA-12
Senators
Dianne Feinstein
Alejandro Padilla
Representative
Barbara Lee
Modified: 9/27/24